Search

Author/Creator Lowy, Andrew M.

3. Dual blockade of epidermal growth factor receptor and insulin‐like growth factor receptor–1 signaling in metastatic pancreatic cancer: Phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727). Issue 19 (16th July 2014)

Authors:
Philip, Philip A.; Goldman, Bryan; Ramanathan, Ramesh K.; Lenz, Heinz‐Josef; Lowy, Andrew M.; Whitehead, Robert P.; Wakatsuki, Takeru; Iqbal, Syma; Gaur, Rakesh; Benedetti, Jacqueline K.; Blanke, Charles D.
Journal:
Cancer
Issue:
Volume 120:Issue 19(2014)
Page Start:
2980
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Dual blockade of epidermal growth factor receptor and insulin‐like growth factor receptor–1 signaling in metastatic pancreatic cancer: Phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727). Issue 19 (16th July 2014)

Authors:
Philip, Philip A.; Goldman, Bryan; Ramanathan, Ramesh K.; Lenz, Heinz‐Josef; Lowy, Andrew M.; Whitehead, Robert P.; Wakatsuki, Takeru; Iqbal, Syma; Gaur, Rakesh; Benedetti, Jacqueline K.; Blanke, Charles D.
Journal:
Cancer
Issue:
Volume 120:Issue 19(2014)
Page Start:
2980
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. GPR68, a proton‐sensing GPCR, mediates interaction of cancer‐associated fibroblasts and cancer cells. Issue 3 (3rd January 2018)

Authors:
Wiley, Shu Z.; Sriram, Krishna; Liang, Wenjing; Chang, Sarah E.; French, Randall; McCann, Thalia; Sicklick, Jason; Nishihara, Hiroshi; Lowy, Andrew M.; Insel, Paul A.
Journal:
FASEB journal
Issue:
Volume 32:Issue 3(2018)
Page Start:
1170
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways. Issue 5 (5th July 2020)

Authors:
Eng, Oliver S.; Blakely, Andrew M.; Lafaro, Kelly J.; Fournier, Keith F.; Fackche, Nadege T.; Johnston, Fabian M.; Dineen, Sean; Powers, Benjamin; Hendrix, Ryan; Lambert, Laura A.; Ronnekleiv‐Kelly, Sean; Walle, Kara Vande; Grotz, Travis E.; Leiting, Jennifer L.; Patel, Sameer H.; Dhar, Vikrom K....
Journal:
Journal of surgical oncology
Issue:
Volume 122:Issue 5(2020)
Page Start:
980
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question—Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial. (March 2020)

Authors:
Abrams, Ross A.; Winter, Kathryn A.; Safran, Howard; Goodman, Karyn A.; Regine, William F.; Berger, Adam C.; Gillin, Michael T.; Philip, Philip A.; Lowy, Andrew M.; Wu, Abraham; DiPetrillo, Thomas A.; Corn, Benjamin W.; Seaward, Samantha A.; Haddock, Michael G.; Song, Suisui; Jiang, Yixing; Fishe...
Journal:
American journal of clinical oncology
Issue:
Volume 43:Number 3(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗